-
1
-
-
0035990834
-
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: Effects on estrogens and bone metabolism
-
E. Bajetta, A. Martinetti, N. Zilembo, P. Pozzi, I. La Torre, L. Ferrari, E. Seregni, R. Longarini, G. Salvucci, and E. Bombardieri Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism Annals of Oncology 13 2002 1059 1066
-
(2002)
Annals of Oncology
, vol.13
, pp. 1059-1066
-
-
Bajetta, E.1
Martinetti, A.2
Zilembo, N.3
Pozzi, P.4
La Torre, I.5
Ferrari, L.6
Seregni, E.7
Longarini, R.8
Salvucci, G.9
Bombardieri, E.10
-
2
-
-
0034982329
-
Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors
-
A.S. Bhatnagar, A.M. Brodie, B.J. Long, D.B. Evans, and W.R. Miller Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors Journal of Steroid Biochemistry and Molecular Biology 76 2001 199 202
-
(2001)
Journal of Steroid Biochemistry and Molecular Biology
, vol.76
, pp. 199-202
-
-
Bhatnagar, A.S.1
Brodie, A.M.2
Long, B.J.3
Evans, D.B.4
Miller, W.R.5
-
3
-
-
0032974113
-
Aromatase inhibitors and their antitumor effects in model systems
-
A. Brodie, Q. Lu, Y. Liu, and B. Long Aromatase inhibitors and their antitumor effects in model systems Endocrine-Related Cancer 6 1999 205 210
-
(1999)
Endocrine-Related Cancer
, vol.6
, pp. 205-210
-
-
Brodie, A.1
Lu, Q.2
Liu, Y.3
Long, B.4
-
4
-
-
0042745380
-
Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer
-
A.U. Buzdar Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer Oncologist 8 2003 335 341
-
(2003)
Oncologist
, vol.8
, pp. 335-341
-
-
Buzdar, A.U.1
-
6
-
-
0037974907
-
Hormonal therapy in postmenopausal women with breast cancer
-
S.M. Campos, and E.P. Winer Hormonal therapy in postmenopausal women with breast cancer Oncology 64 2003 289 299
-
(2003)
Oncology
, vol.64
, pp. 289-299
-
-
Campos, S.M.1
Winer, E.P.2
-
8
-
-
0029015406
-
Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: Comparison of the TCA-100 assay with a clonogenic assay
-
I.A. Cree, M. Pazzagli, E. Mini, T. Mazzei, E.M. Hunter, L.A. Sutherland, P. Pinzani, A. Gerli, and P.E. Andreotti Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay Anticancer Drugs 6 1995 398 404
-
(1995)
Anticancer Drugs
, vol.6
, pp. 398-404
-
-
Cree, I.A.1
Pazzagli, M.2
Mini, E.3
Mazzei, T.4
Hunter, E.M.5
Sutherland, L.A.6
Pinzani, P.7
Gerli, A.8
Andreotti, P.E.9
-
9
-
-
0036862696
-
Aromatase Inhibitors in Breast Cancer: An Update
-
Diana E. Lake, and Clifford Hudis Aromatase Inhibitors in Breast Cancer: An Update Cancer Control 9 2002 490 497
-
(2002)
Cancer Control
, vol.9
, pp. 490-497
-
-
Lake Diana, E.1
Clifford, H.2
-
10
-
-
0034901971
-
Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer
-
J. Geisler, S. Detre, H. Berntsen, L. Ottestad, B. Lindtjorn, M. Dowsett, and P. Einstein Lonning Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer Clinical Cancer Research 7 2001 1230 1236
-
(2001)
Clinical Cancer Research
, vol.7
, pp. 1230-1236
-
-
Geisler, J.1
Detre, S.2
Berntsen, H.3
Ottestad, L.4
Lindtjorn, B.5
Dowsett, M.6
Einstein Lonning, P.7
-
11
-
-
0000773766
-
Emerging role of aromatase inhibitors in the treatment of breast cancer
-
H.A. Harvey Emerging role of aromatase inhibitors in the treatment of breast cancer Oncology (Huntingt) 12 Suppl 5 1998 32 35
-
(1998)
Oncology (Huntingt)
, vol.12
, Issue.5
, pp. 32-35
-
-
Harvey, H.A.1
-
12
-
-
0027162268
-
Heterogeneity of chemosensitivity in human breast carcinoma: Use of an adenosine triphosphate (ATP) chemiluminescence assay
-
E.M. Hunter, L.A. Sutherland, I.A. Cree, J.A. Dewar, P.E. Preece, R.A. Wood, D. Linder, and P.E. Andreotti Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay European Journal of Surgical Oncology 19 1993 242 249
-
(1993)
European Journal of Surgical Oncology
, vol.19
, pp. 242-249
-
-
Hunter, E.M.1
Sutherland, L.A.2
Cree, I.A.3
Dewar, J.A.4
Preece, P.E.5
Wood, R.A.6
Linder, D.7
Andreotti, P.E.8
-
13
-
-
0027162268
-
Heterogeneity of chemosensitivity in human breast carcinoma: Use of an adenosine triphosphate (ATP) chemiluminescence assay
-
E.M. Hunter, L.A. Sutherland, I.A. Cree, J.A. Dewar, P.E. Preece, R.A. Wood, D. Linder, and P.E. Andreotti Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay European Journal of Surgical Oncology 19 1993 242 249
-
(1993)
European Journal of Surgical Oncology
, vol.19
, pp. 242-249
-
-
Hunter, E.M.1
Sutherland, L.A.2
Cree, I.A.3
Dewar, J.A.4
Preece, P.E.5
Wood, R.A.6
Linder, D.7
Andreotti, P.E.8
-
14
-
-
0030910244
-
Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation
-
H.A. Kester, B.M. van der Leede, P.T. van der Saag, and B. van der Burg Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation Journal of Biological Chemistry 272 1997 16637 16643
-
(1997)
Journal of Biological Chemistry
, vol.272
, pp. 16637-16643
-
-
Kester, H.A.1
Van Der Leede, B.M.2
Van Der Saag, P.T.3
Van Der Burg, B.4
-
15
-
-
0038682099
-
ATP chemosensitivity testing in ovarian and breast cancer: Early clinical trials
-
C.M. Kurbacher, O.M. Grecu, U. Stier, T.J. Gilster, M.M. Janat, M. Untch, G. Konecny, H.W. Bruckner, and I.A. Cree ATP chemosensitivity testing in ovarian and breast cancer: early clinical trials Recent Results in Cancer Research 161 2003 221 230
-
(2003)
Recent Results in Cancer Research
, vol.161
, pp. 221-230
-
-
Kurbacher, C.M.1
Grecu, O.M.2
Stier, U.3
Gilster, T.J.4
Janat, M.M.5
Untch, M.6
Konecny, G.7
Bruckner, H.W.8
Cree, I.A.9
-
16
-
-
0029997644
-
Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay
-
C.M. Kurbacher, P. Mallmann, J.A. Kurbacher, H. Hubner, and D. Krebs Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay Geburtshilfe Frauenheilkd 56 1996 70 78
-
(1996)
Geburtshilfe Frauenheilkd
, vol.56
, pp. 70-78
-
-
Kurbacher, C.M.1
Mallmann, P.2
Kurbacher, J.A.3
Hubner, H.4
Krebs, D.5
-
17
-
-
0037087535
-
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer
-
A. Lipton, S.M. Ali, K. Leitzel, L. Demers, V. Chinchilli, L. Engle, H.A. Harvey, C. Brady, C.M. Nalin, M. Dugan, W. Carney, and J. Allard Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancer Journal of Clinical Oncology 20 2002 1467 1472
-
(2002)
Journal of Clinical Oncology
, vol.20
, pp. 1467-1472
-
-
Lipton, A.1
Ali, S.M.2
Leitzel, K.3
Demers, L.4
Chinchilli, V.5
Engle, L.6
Harvey, H.A.7
Brady, C.8
Nalin, C.M.9
Dugan, M.10
Carney, W.11
Allard, J.12
-
19
-
-
0029655552
-
Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and-negative breast carcinomas
-
H. Naundorf, K. Parczyk, W. Zschiesche, S. Reinecke, B. Buttner, G.J. Saul, B. Sinn, and I. Fichtner Relation of oestradiol-mediated growth stimulation with the expression of c-erbB-2 protein in xenotransplanted oestradiol-receptor-positive and-negative breast carcinomas Journal of Cancer Research and Clinical Oncology 122 1996 14 20
-
(1996)
Journal of Cancer Research and Clinical Oncology
, vol.122
, pp. 14-20
-
-
Naundorf, H.1
Parczyk, K.2
Zschiesche, W.3
Reinecke, S.4
Buttner, B.5
Saul, G.J.6
Sinn, B.7
Fichtner, I.8
-
20
-
-
0028997307
-
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells
-
R.J. Pietras, J. Arboleda, D.M. Reese, N. Wongvipat, M.D. Pegram, L. Ramos, C.M. Gorman, M.G. Parker, M.X. Sliwkowski, and D.J. Slamon HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells Oncogene 10 1995 2435 2446
-
(1995)
Oncogene
, vol.10
, pp. 2435-2446
-
-
Pietras, R.J.1
Arboleda, J.2
Reese, D.M.3
Wongvipat, N.4
Pegram, M.D.5
Ramos, L.6
Gorman, C.M.7
Parker, M.G.8
Sliwkowski, M.X.9
Slamon, D.J.10
-
22
-
-
0036368263
-
In situ production of estrogens in human breast carcinoma
-
T. Suzuki, T. Moriya, T. Ishida, M. Kimura, N. Ohuchi, and H. Sasano In situ production of estrogens in human breast carcinoma Breast Cancer 9 2002 296 302
-
(2002)
Breast Cancer
, vol.9
, pp. 296-302
-
-
Suzuki, T.1
Moriya, T.2
Ishida, T.3
Kimura, M.4
Ohuchi, N.5
Sasano, H.6
-
23
-
-
0028852057
-
Metabolic imaging in tumours by means of bioluminescence
-
P. Tamulevicius, and C. Streffer Metabolic imaging in tumours by means of bioluminescence British Journal of Cancer 72 1995 1102 1112
-
(1995)
British Journal of Cancer
, vol.72
, pp. 1102-1112
-
-
Tamulevicius, P.1
Streffer, C.2
-
24
-
-
0034766736
-
Biology of HER2 and its importance in breast cancer
-
Y. Yarden Biology of HER2 and its importance in breast cancer Oncology 61 Suppl 2 2001 1 13
-
(2001)
Oncology
, vol.61
, Issue.2
, pp. 1-13
-
-
Yarden, Y.1
|